The Chains of Ferroptosis Interact in the Whole Progression of Atherosclerosis

Xueqi Wan1, Huan Zhang1, Jinfan Tian1

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.

PubMed

Insights

Ferroptosis, a novel cell death pathway involving iron, impacts cardiovascular diseases like atherosclerosis. Understanding ferroptosis mechanisms offers new therapeutic targets for atherosclerosis progression.

Area of Science:

  • Biomedical Science
  • Cardiovascular Research
  • Cellular Biology

Background:

  • Atherosclerosis (AS) is a major cardiovascular disease (CVD) with complex pathogenesis and limited therapeutic options.
  • Ferroptosis is a distinct programmed cell death pathway characterized by iron accumulation and lipid peroxidation.
  • Ferroptosis plays a role in various cardiovascular conditions, including AS, stroke, and heart failure.

Purpose of the Study:

  • To systematically review the initiation and modulation of ferroptosis.
  • To summarize the contribution of ferroptosis to the pathology of atherosclerosis.
  • To explore ferroptosis as a potential therapeutic target for AS.

Main Methods:

  • Literature review of ferroptosis mechanisms and its role in cardiovascular diseases.
  • Systematic analysis of molecular pathways involved in ferroptosis.
  • Synthesis of current understanding of ferroptosis in the context of atherosclerosis.

Main Results:

  • Ferroptosis is characterized by iron overload, redox imbalance, and lipid hydroperoxide accumulation.
  • Ferroptosis affects key cardiovascular cells like endothelial cells, VSMCs, and macrophages.
  • Ferroptosis is implicated in the inflammatory processes underlying AS.

Conclusions:

  • Ferroptosis is a significant contributor to atherosclerosis development and progression.
  • Targeting ferroptosis pathways presents a promising therapeutic strategy for managing AS.
  • Further research into ferroptosis mechanisms may unveil novel treatments for cardiovascular diseases.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Inflammation01:38

Inflammation

Overview
53.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11